Dear Colleague,
Following the excellent response to our call for abstracts, we are pleased to inform you that we have extended the abstract submission deadline for CRISPR: From Biology to Technology and Novel Therapeutics until June 23, 2017, to allow participants additional time to complete their submissions.
Here is a reminder of our exciting speaker line-up:
- Charlie Albright, Chief Scientific Officer, Editas Medicine,USA
- Chase Beisel, North Carolina State University, USA
- Juan-Carlos Izpisua Belmonte, Salk Institute, USA
- Paula Cannon, University of Southern California, USA
- Jacob Corn, University College Berkeley, USA
- Alan Davidson, University of Toronto, Canada
- Charles Gersbach, Duke University, USA
- Maria Jasin, Sloan-Kettering Cancer Center, USA
- Martin Jinek, University of Zurich, Switzerland
- J. Keith Joung, Massachusetts General Hospital, Harvard Medical School, USA
- Nancy Maizels, University of Washington, USA
- Andy May, Chan-Zuckerberg BioHub, USA
- Luigi Naldini, Telethon Institute Milan, Italy
- Tony Nolan, Imperial College London, UK
- John van der Oost, Waginengen University, The Netherlands
- Michel Sadelain, Sloan Kettering Cancer Center, USA
- Blake Wiedenheft, Montana State University, USA
Don’t miss your chance to present your own CRISPR research at this unique symposium.
![Submit Abstract Here](http://csemails.elsevier.com/CONF/cellcrispr/submit_here_button.png)
Yours sincerely,
J. Keith Joung, Massachusetts General Hospital, Harvard Medical School, USA
Andrew May, Chan-Zuckerberg BioHub, USA
John Pham, Chief Editor, Molecular Cell
Jonathan Saxe, Editor, Cell Stem Cell |